PharmaTher Holdings Ltd.
CNQ: PHRM.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Fabio Chianelli
- Headquarters
- Toronto, Canada
- IPO year
- 2021
- Market cap
- CA$6.8M
- Website
- https://www.pharmather.com
Loading PHRM…
Loading profile data…Frequently asked questions about PHRM
What does PharmaTher Holdings Ltd. (PHRM.CN) do?
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Ph...
Where does PHRM.CN trade?
PharmaTher Holdings Ltd. (PHRM.CN) trades on the Canadian Securities Exchange.
What sector is PHRM.CN in?
PharmaTher Holdings Ltd. (PHRM.CN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PharmaTher Holdings Ltd.?
Fabio Chianelli is the chief executive officer of PharmaTher Holdings Ltd. (PHRM.CN).
Where is PharmaTher Holdings Ltd. headquartered?
PharmaTher Holdings Ltd. is headquartered in Canada.
Does PHRM.CN pay a dividend?
PharmaTher Holdings Ltd. (PHRM.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PHRM.CN go public?
PharmaTher Holdings Ltd. (PHRM.CN) completed its initial public offering in 2021.